Eric I. Richman
CIK: 0001313876
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GANX
Gain Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About RICHMAN ERIC I
RICHMAN ERIC I (SEC CIK 0001313876) files insider reports with the SEC as Director of Gain Therapeutics, Inc. (GANX).
Signal8 holds 1 ownership filing by RICHMAN ERIC I, a Form 4, filed on Jun 25, 2025. Those filings report 1 transaction, the latest on Jun 24, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on RICHMAN ERIC I's filings is in BETHESDA, MD.
Recent filings by RICHMAN ERIC I
- Jun 24, 2025: Grant or award of GANX derivative securities (Form 4, code A).
Other insiders filing for Gain Therapeutics, Inc. (GANX)
- Weidner Jeanette
- GOLDSTEIN DOV A MD, Director
- Nicaise Claude, Director
- Islam Khalid, Director
- Melincoff Gwen A, Director
- Riley Jeffrey Scott, Director